Key excerpts: PhRMA submits comments to NIST in effort to safeguard intellectual property protections

Earlier this week PhRMA submittedcomments to the National Institute of Standards and Technology (NIST) regarding the proposed rulemaking on implementing regulations of the Bayh-Dole Act. Passed in 1980, the Bayh-Dole Act was a landmark piece of bipartisan legislation that established a uniform framework across the federal government to encourage technology transfer between universities and the private sector that has facilitated timely and efficient commercialization of early-stage research. Since its passage, it has fueled unprecedented innovation across the United States.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Intellectual Property Source Type: news